Fidia SpA (MIL:FDA) Current Deferred Revenue: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Fidia SpA Current Deferred Revenue?

Fidia SpA MIL:FDA +8.70% Current Deferred Revenue is €0.00 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Fidia SpA's current deferred revenue for the quarter that ended in Dec. 2025 was €0.00 Mil.

Fidia SpA Current Deferred Revenue Related Terms

Fidia SpA Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Fidia SpA's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fidia SpA Current Deferred Revenue Chart

Fidia SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fidia SpA Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of €0.00 Mil mean?
Fidia SpA (MIL:FDA) has a Current Deferred Revenue of €0.00 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fidia SpA and its competitors.
Is Fidia SpA's Current Deferred Revenue too high?
Fidia SpA's current Current Deferred Revenue is €0.00 Mil.
How does Fidia SpA's Current Deferred Revenue compare to GEV and ETN?
Fidia SpA's Current Deferred Revenue of €0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for an Industrial Products company?
A good Current Deferred Revenue depends on the Industrial Products industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fidia SpA and its competitors. Fidia SpA's current Current Deferred Revenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fidia SpA stock overvalued right now?
Based on GuruFocus' analysis, Fidia SpA (MIL:FDA) is currently considered Fairly Valued. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading right at its estimated fair value. The current Current Deferred Revenue is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Fidia SpA (MIL:FDA), the current Current Deferred Revenue is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fidia SpA Business Description

Other Exchanges FIC0:Germany
Address Corso Lombardia, 11, San Mauro Torinese, Turin, ITA, 10099
Fidia SpA is engaged in designing, producing, and marketing machine tools for use in machining molds with complex shapes. Its product portfolio includes CNC numerical controls, high speed milling systems, digital controls, variators, milling head control, digital drives, button panels, and calibration systems among others. The company also provides after-sales services and offers computer-assisted manufacturing (CAM) software used for the automated creation of machine-tool digital control programs. Geographically, the company generates maximum revenue from North and South America followed by Asia, Europe (excluding Italy), Italy, and the Rest of the world.